Oxytocin
Oxytocin Acetate · Ocytocin
Oxytocin is a disulfide-containing nonapeptide hormone. The catalogue product is named Oxytocin Acetate; the peptide reference and the salt designation need to be kept distinct.
Reviewed September 2026
- Residues
- 9. verified: 9 residues in the cyclic-disulfide, C-terminally amidated reference peptide.
- Average mass
- 1,007.2 Da. verified: Reference form: Oxytocin with Cys1–Cys6 disulfide and C-terminal glycinamide; peptide moiety only, not an unspecified acetate/hydrate.; formula C43H66N12O12S2. PubChem average molecular weight, not monoisotopic mass. Excludes unlisted counterions, solvent and formulation ingredients; not a sold-lot measurement.
- pI
- Not established. unverified: No documented pI or validated full modification-aware ionization model was established for this exact reference form. Terminal chemistry, noncanonical residues, lipidation, cyclization or non-alpha linkages cannot be silently omitted. Not formulation pH.
Reference details
| Residues | 9 |
|---|---|
| Average mass | 1,007.2 Da |
| pI | Not established |
| Aliases | Oxytocin Acetate, Ocytocin |
|---|---|
| Research area | Endocrine |
| PubChem CID | 439302 |
Property basis and sources
These describe the reference compound or formulation, not identification or testing of the supplied lot.
Oxytocin with Cys1–Cys6 disulfide and C-terminal glycinamide; peptide moiety only, not an unspecified acetate/hydrate. Reference only, not a sold-lot measurement.
- Residues: 9 (verified). 9 residues in the cyclic-disulfide, C-terminally amidated reference peptide. Residues source 1
- Average mass: 1,007.2 Da (verified). Reference form: Oxytocin with Cys1–Cys6 disulfide and C-terminal glycinamide; peptide moiety only, not an unspecified acetate/hydrate.; formula C43H66N12O12S2. PubChem average molecular weight, not monoisotopic mass. Excludes unlisted counterions, solvent and formulation ingredients; not a sold-lot measurement. Average mass source 1
- pI: Not established (unverified). No documented pI or validated full modification-aware ionization model was established for this exact reference form. Terminal chemistry, noncanonical residues, lipidation, cyclization or non-alpha linkages cannot be silently omitted. Not formulation pH. pI source 1
Reference scope and linked records
Reference type: Cyclic peptide; acetate product context.
This is a research-reference entry, not a product certificate, treatment recommendation or administration guide. The sources below describe their own materials and methods. Catalogue identity, lot testing and clinical evidence are separate questions.
Catalogue context: Oxytocin Acetate. The product retains its own name and specification; this link does not certify equivalence to published study material.
Related references
Sources and their scope
- PubChem: oxytocin, CID 439302. Source for the chemistry or study context discussed above; not an Aminos lot certificate.
Source check: 26 September 2026. This is an editorial source check, not a claim of independent clinical or laboratory review.
About Oxytocin
Identity and context
The reference sequence is CYIQNCPLG, with a disulfide between the cysteines and a C-terminal amide. Those structural details are essential. Acetate describes the supplied chemical form and must not be counted as an extra amino-acid residue.
Reference classification
Cyclic peptide; acetate product context. The linked catalogue product is Oxytocin Acetate. This reference does not independently authenticate the material supplied.
Storage and handling
Analytical specification
Ask for the peptide identity, intact disulfide and acetate specification. Confirm whether any assay or stated amount is reported on a peptide-equivalent or total-material basis, rather than assuming these are identical.
Storage and experimental handling
Use the documented conditions for the actual chemical form and preparation. No universal storage temperature, expiry or solution shelf life is assigned here. Follow the lot documentation, safety data sheet and validated laboratory protocol; this page is not a reconstitution or administration guide.
Research evidence
| Area | Summary | Evidence |
|---|---|---|
| What the source examines | PubChem provides the chemically defined oxytocin structure. It supports identification of the peptide moiety, including its ring-forming linkage, rather than a claim about a supplier lot or an unspecified formulation. | Source context |
| What cannot be inferred | Clinical uses of regulated oxytocin medicines do not establish authorization, quality or suitability of an Aminos preparation. This entry does not infer social, behavioural or obstetric effects for the catalogue product. | Evidence limits |
References
Sources used for the data on this page, checked September 2026.
- PubChem: oxytocin, CID 439302Primary source for the reference discussion; not lot-specific product evidence.
Reference information only. This page describes the chemistry and published research context of a laboratory compound. Nothing here is medical or dosing advice. Aminos compounds are for laboratory research use only and are not medicines.